Skip to main content
SpringerLink
Log in

Increased peritoneal permeability in patients with peritonitis undergoing continuous ambulatory peritoneal dialysis

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The distribution of cefuroxime (250 mg) was studied in patients with renal failure undergoing continuous ambulatory peritoneal dialysis (CAPD). 10 uninfected patients received the drug intravenously and intraperitoneally, while 9 patients with peritonitis were randomly allocated to intravenous or intraperitoneal administration. Samples were taken over the first 6 hour dialysis period. In the infected patients, more drug (p<0.01) crossed into the peritoneal cavity following intravenous injection and reached the systemic circulation following intraperitoneal administration than in the uninfected group. This increased permeability of the peritoneal membrane during infection may result in unexpected systemic toxicity in patients treated with intraperitoneal antibiotics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Popovich RP, Moncrief EW, Nolph KD, Ghods AJ, Twardowski ZJ, Pyle WK (1978) Continuous ambulatory peritoneal dialysis. Ann Intern Med 88: 449–456

    Google Scholar 

  2. Kurtz SB, Wong VH, Anderson CF, Vogel JP, McCarthy JT, Mitchell JK, Kumar R, Johnson WJ (1983) Continuous ambulatory peritoneal dialysis — Three years' experience at the Mayo Clinic. Mayo Clinic Proc 53: 633–639

    Google Scholar 

  3. Gokal R, Ramos JM, Francis DMA, Ferner RE, Goodship THJ, Proud G, Bint AJ, Ward MK, Kerr DNS (1982) Peritonitis in continuous ambulatory peritoneal dialysis. Lancet 2: 1388–1391

    Google Scholar 

  4. Smith BR, Le Frock JL (1983) Cefuroxime: antimicrobial activity, pharmacology, and clinical efficacy. Ther Drug Monit 5: 149–160

    Google Scholar 

  5. Singlas E, Colin JN, Rottembourg J, Meesen JP, De Martin A, Legrain M, Simon P (1982) Pharmacokinetics of sulphathoxazole-trimethoprim combination during chronic peritoneal dialysis: effect of peritonitis. Eur J Clin Pharmacol 21: 409–415

    Google Scholar 

  6. De Paepe M, Lameire N, Belpaire F, Bogaert M (1983) Peritoneal pharmacokinetics of gentamicin in man. Clin Nephrol 19: 107–109

    Google Scholar 

  7. Walstad RA, Nilsen OG, Berg KJ (1983) Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency. Eur J Clin Pharmacol 24: 391–398

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, Nephrology and Clinical Pharmacology Western Infirmary, Glasgow, Scotland

    M. E. McIntosh, W. G. J. Smith, B. J. R. Junor, G. Forrest & M. J. Brodie

Authors
  1. M. E. McIntosh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. G. J. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. J. R. Junor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Forrest
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. J. Brodie
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McIntosh, M.E., Smith, W.G.J., Junor, B.J.R. et al. Increased peritoneal permeability in patients with peritonitis undergoing continuous ambulatory peritoneal dialysis. Eur J Clin Pharmacol 28, 187–191 (1985). https://doi.org/10.1007/BF00609690

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00609690

Key words

Search

Navigation